Literature DB >> 21172844

Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?

J L Whitwell1, C R Jack, J E Parisi, M L Senjem, D S Knopman, B F Boeve, R Rademakers, M Baker, R C Petersen, D W Dickson, K A Josephs.   

Abstract

OBJECTIVE: To determine whether TDP-43 type is associated with distinct patterns of brain atrophy on MRI in subjects with pathologically confirmed frontotemporal lobar degeneration (FTLD).
METHODS: In this case-control study, we identified all subjects with a pathologic diagnosis of FTLD with TDP-43 immunoreactive inclusions (FTLD-TDP) and at least one volumetric head MRI scan (n = 42). In each case we applied published criteria for subclassification of FTLD-TDP into FTLD-TDP types 1-3. Voxel-based morphometry was used to compare subjects with each of the different FTLD-TDP types to age- and gender-matched normal controls (n = 30). We also assessed different pathologic and genetic variants within, and across, the different types.
RESULTS: Twenty-two subjects were classified as FTLD-TDP type 1, 9 as type 2, and 11 as type 3. We identified different patterns of atrophy across the types with type 1 showing frontotemporal and parietal atrophy, type 2 predominantly anterior temporal lobe atrophy, and type 3 predominantly posterior frontal atrophy. Within the FTLD-TDP type 1 group, those with a progranulin mutation had significantly more lateral temporal lobe atrophy than those without. All type 2 subjects were diagnosed with semantic dementia. Subjects with a pathologic diagnosis of FTLD with motor neuron degeneration had a similar pattern of atrophy, regardless of whether they were type 1 or type 3.
CONCLUSIONS: Although there are different patterns of atrophy across the different FTLD-TDP types, it appears that genetic and pathologic factors may also affect the patterns of atrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172844      PMCID: PMC3013590          DOI: 10.1212/WNL.0b013e31820203c2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

4.  A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory.

Authors:  C J Mummery; K Patterson; C J Price; J Ashburner; R S Frackowiak; J R Hodges
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

5.  A short test of mental status: description and preliminary results.

Authors:  E Kokmen; J M Naessens; K P Offord
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

6.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.

Authors:  D Chan; N C Fox; R I Scahill; W R Crum; J L Whitwell; G Leschziner; A M Rossor; J M Stevens; L Cipolotti; M N Rossor
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

7.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

Review 8.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

View more
  42 in total

Review 1.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

2.  Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes.

Authors:  Pamela M Dean; Glenn E Smith; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Keith A Josephs
Journal:  J Clin Neurosci       Date:  2013-09-04       Impact factor: 1.961

3.  Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Neurology       Date:  2013-06-26       Impact factor: 9.910

4.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

5.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

6.  Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; David S Knopman; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2019-05-02       Impact factor: 21.566

7.  Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.

Authors:  Alma Ghirelli; Nirubol Tosakulwong; Stephen D Weigand; Heather M Clark; Farwa Ali; Hugo Botha; Joseph R Duffy; Rene L Utianski; Marina Buciuc; Melissa E Murray; Sydney A Labuzan; Anthony J Spychalla; Nha Trang Thu Pham; Christopher G Schwarz; Matthew L Senjem; Mary M Machulda; Matthew Baker; Rosa Rademakers; Massimo Filippi; Clifford R Jack; Val J Lowe; Joseph E Parisi; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Ann Neurol       Date:  2020-09-12       Impact factor: 10.422

8.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Sandra Weintraub; Emily J Rogalski; Christina Wieneke; Changiz Geula; Eileen H Bigio
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501

9.  Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.

Authors:  Yujing Zhao; Dana L Tudorascu; Oscar L Lopez; Ann D Cohen; Chester A Mathis; Howard J Aizenstein; Julie C Price; Lewis H Kuller; M Ilyas Kamboh; Steven T DeKosky; William E Klunk; Beth E Snitz
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

Review 10.  Neuroimaging features of C9ORF72 expansion.

Authors:  Jennifer S Yokoyama; Howard J Rosen
Journal:  Alzheimers Res Ther       Date:  2012-11-16       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.